ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $958,881 | -33.0% | 286,233 | -3.9% | 0.00% | – |
| Q4 2022 | $1,432,129 | +10.4% | 297,740 | +30.6% | 0.00% | – |
| Q3 2022 | $1,297,000 | +107.2% | 227,965 | +158.4% | 0.00% | – |
| Q2 2022 | $626,000 | -1.7% | 88,211 | -0.1% | 0.00% | – |
| Q1 2022 | $637,000 | +0.3% | 88,341 | +24.2% | 0.00% | – |
| Q4 2021 | $635,000 | -11.2% | 71,106 | +248.7% | 0.00% | – |
| Q3 2021 | $715,000 | -93.2% | 20,390 | -95.8% | 0.00% | -100.0% |
| Q2 2021 | $10,511,000 | +301.6% | 489,345 | +1055.0% | 0.00% | – |
| Q1 2021 | $2,617,000 | +46.7% | 42,366 | -0.8% | 0.00% | – |
| Q4 2020 | $1,784,000 | – | 42,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,637,331 | $57,405,000 | 37.04% |
| Bain Capital Life Sciences Investors, LLC | 3,700,000 | $129,722,000 | 8.05% |
| Cormorant Asset Management, LP | 4,928,756 | $172,802,000 | 7.02% |
| RA Capital Management | 5,427,655 | $190,294,000 | 2.64% |
| CM Management, LLC | 100,000 | $3,506,000 | 2.62% |
| Ghost Tree Capital, LLC | 150,000 | $5,259,000 | 1.54% |
| ORACLE INVESTMENT MANAGEMENT INC | 309,126 | $10,838,000 | 1.35% |
| Perceptive Advisors | 2,259,224 | $79,208,000 | 1.15% |
| Omega Fund Management, LLC | 164,577 | $5,770,000 | 0.65% |
| Monashee Investment Management LLC | 100,000 | $3,506,000 | 0.65% |